Abstract
Apoptosis is an important area of research because of its role in keeping a mature multicellular organism’s number of cells constant, hence, ensuring that the organism does not have cell accumulation that may transform into cancer with additional hallmarks. Firstly, we have carried out sensitivity analysis on an existing mathematical mitochondria-dependent apoptosis model to find out which parameters have a role in causing monostable cell survival, which may, in turn, lead to malfunction in apoptosis. We have then generated three base parameter sets that represent healthy cells. These parameter sets were built by changing the sensitive parameters while preserving the bistability. For each base set, we varied the proapoptotic and antiapoptotic production rates, to yield new sets for the cells that have malfunctioning apoptosis. In a hypothetical cell model, we simulated caspase-3 activation by numerically integrating the governing ordinary differential equations of a mitochondria-dependent apoptosis model. These simulations were carried out for four potential treatments, namely: (1) proteasome inhibitor treatment, (2) Bcl-2 inhibitor treatment, (3) IAP inhibitor treatment, (4) Bid-like synthetic peptides treatment. The results suggest that the proteasome inhibitor treatment is the most effective treatment, though it may have severe side effects. For this treatment, the amount of proteasome inhibitor needed for caspase-3 activation may be different for hypothetical cells with a different pro- or anti-apoptotic protein defect. It is also found that caspase-3 can be activated by Bcl-2 inhibitor treatment only in those hypothetical malfunctioning cells with Bax deficiency but not in others. These results are in line with the view that molecular heterogeneity in individuals may be an important factor in determining the individuals’ positive or negative responses to treatments.
References
Betensky RA, Louis DN, Cairncross JG. Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol. 2002;20:2495–9. doi:10.1200/JCO.2002.06.140.
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene. 2004;23:2934–49. doi:10.1038/sj.onc.1207515.
Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in apoptosis: roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophys J. 2006;90:1546–59. doi:10.1529/biophysj.105.068122.
Hector S, Prehn JHM. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochim Biophys Acta. 2009;1795:117–29. doi:10.1016/j.bbcan.2008.12.002.
Nair VD, Yuen T, Olanow CW, Sealfon SC. Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem. 2004;279:27494–501. doi:10.1074/jbc.M3121352006.
Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell. 2011;144:926–39. doi:10.1016/j.cell.2011.03.002.
Li H, Yi T, Wu Z. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BMC Cancer. 2008;8:135–41. doi:10.1186/1471-2407-8-135.
Fussenegger M, Bailey JE, Varner J. A mathematical model of caspase function in apoptosis. Nat Biotechnol. 2000;18:768–74. doi:10.1038/77589.
Eissing T, Conzelmann H, Gilles ED, Allgower F, Bullinger E, Scheurich P. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J Biol Chem. 2004;279:36892–7. doi:10.1074/jbc.M404893200.
Salvioli S, Capri M, Tieri P, Loroni J, Barbi C, Invidia L, Altilia S, Santoro A, Pirazzini C, Pierini M, Bellavista E, Alberghina L, Franceschi C. Different types of cell death in organismal aging and longevity: state of the art and possible systems biology approach. Curr Pharm Des. 2008;14:226–36. doi:10.2174/138161208783413266.
Albeck JG, Burke JM, Spencer SL, Lauffenburger DA, Sorger PK. Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 2008;6:2831–52. doi:10.1371/journal.pbio.0060299.
Albeck JG, Burke JM, Spencer SM, Lauffenburger DA, Sorger PK. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell. 2008;30:11–25. doi:10.1016/j.molcel.2008.02.012.
Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout B, Bahar I. Computational insights on the competing effects of nitric oxide in regulating apoptosis. PLoS ONE. 2008;3:e2249. doi:10.1371/journal.pone.0002249.
Golovchenko EN, Hanin LG, Kaufmann SH, Tyurin KV, Khanin MA. Dynamics of granzyme B-induced apoptosis: mathematical modeling. Math Biosci. 2008;212:54–68. doi:10.1016/j.mbs.2007.12.002.
Han L, Zhao Y, Jia X. Mathematical modeling identified c-FLIP as an apoptotic switch in death receptor induced apoptosis. Apoptosis. 2008;13:198–1204. doi:10.1007/s10495-008-0252-3.
Harrington KA, Ho KL, Ghosh S, Tung KC. Construction and analysis of a modular model of caspase activation in apoptosis. Theor Biol Med Model. 2008;5:26–40. doi:10.1186/1742-4682-5-26.
Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem. 2007;282:13664–71.
Legewie S, Blüthgen N, Herzel H. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput Biol. 2006;2:e120. doi:10.1371/journal.pcbi.0020120.
O’Connor CL, Anguissola S, Huber HJ, Dussmann H, Prehn JHM, Rehm M. Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein. Biochim Biophys Acta. 2008;1783:1903–13. doi:10.1016/j.bbamcr.2008.05.025.
Okazaki N, Asano R, Kinoshita T, Chuman H. Simple computational models of type I/type II cells in Fas signaling-induced apoptosis. J Theor Biol. 2008;250:621–33. doi:10.1016/j.jtbi.2007.10.030.
Rangamani P, Sirovich L. Survival and apoptotic pathways initiated by TNF-alpha: modeling and predictions. Biotechnol Bioeng. 2007;97:1216–29. doi:10.1002/bit.21307.
Raychaudhuri S, Wilgohs E, Nguyen TN, Khan EM, Golkorn T. Monte Carlo simulation of cell death signaling predicts large cell-to-cell stochastic fluctuations through the type 2 pathway of apoptosis. Biophys J. 2008;95:3559–62. doi:10.1529/biophysj.108.135483.
Calzone L, Tournier L, Fourquet S, Thieffry D, Zhivotovsky B, Barillot E, Zinovyev A. Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput Biol. 2010;6:e1000702. doi:10.1371/journal.pcbi.1000702.
Zhang TL, Brazhnik P, Tyson JJ. Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. Biophys J. 2009;97:415–34. doi:10.1016/j.bpj.2009.04.053.
Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Sys Biol 6, Art. No. 352 (2010). doi:10.1038/msb.2010.6.
Zhang T, Wu M, Chen Q, Sun ZR. Investigation into the regulation mechanisms of TRAIL apoptosis pathway by mathematical modeling. Acta Biochim Biophys Sin. 2010;42:98–108. doi:10.1093/abbs/gmp114.
Dogu Y, Diaz J. Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis. Biophys Chem. 2009;143:44–54. doi:10.1016/j.bpc.2009.03.012.
Harrington HA, Ho KL, Ghosh S, and Tung KC. Construction and analysis of a modular model of caspase activation in apoptosis. Theor Biol Med Model, 5, Art. No. 26 (2008). doi:10.1186/1742-4682-5-26.
Huber HJ, Plchut M, Weisova P, Dussmann H, Wenus J, Rehm M, Ward MW, Prehn JHM. TOXI-SIM-A simulation tool for the analysis of mitochondrial and plasma membrane potentials. J Neurosci Methods. 2009;176:270–5. doi:10.1016/j.jneumeth.2008.09.003.
Foo J, Leder K, Michor F. Stochastic dynamics of cancer initiation. Phys Biol. 2011;8:015002. doi:10.1088/1478-3975/8/1/015002.
Majumder D, Mukherjee A. A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst. 2011;136:663–78. doi:10.1039/C0AN00746C.
Vainstein V, Kirnasovsky OU, Kogan Y, Agur Z. Strategies for cancer stem cell elimination: insights from mathematical modeling. J Theor Biol. 2012;298:32–41. doi:10.1016/j.jtbi.2011.12.016.
Sen SM, Bagci EZ, Camurdan MC. Bistability analysis of an apoptosis model in the presence of nitric oxide. Bull Math Biol. 2011;73:1952–68. doi:10.1007/s11538-010-9613-5.
di Pietro C, Ragusa M, Barbagallo D, Duro LR, Guglielmino MR, Majorana A, Angelica R, Scalia M, Statello L, Salito L, Tomasello L, Pernagallo S, Valenti S, D’Agostino V, Triberio P, Tandurella I, Palumbo GA, La Cava P, Cafiso V, Bertuccio T, Santagati M, Li Destri G, Lanzafame S, Di Raimondo F, Stefani S, Mishra B, Purrello M. The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma. BMC Med Genomics. 2009;2:20–54. doi:10.1186/1755-8794-2-20.
Weinberg RA. The biology of cancer. New York: Garland Science; 2007.
Ermentrout B. Simulating, analyzing and animating dynamical systems. A guide to XPPAUT for researchers and students. Philadelphia: SIAM; 2002.
Strogatz SH. Nonlinear dynamics and chaos with applications to physics, biology, chemistry and engineering. Cambridge: Westview Press; 2000.
Shoemaker JE, Doyle FJ. Identifying fragilities in biochemical networks: robust performance analysis of Fas signaling-induced apoptosis. Biophys J. 2008;95:2610–23. doi:10.1529/biophysj.107.123398.
Box GE, Hunter WG, Hunter JS. Statistics for experiments. An introduction to design, data analysis, and model building. New York: Wiley; 1978.
Sharma VK, Sharma A, Kumar N, Khandelwal M, Mandapati KK, Horn-Saban S, Strichman-Almashanu L, Lancet D, Brahmachari SK. Expoldb: expression linked polymorphism database with inbuilt tools for analysis of expression and simple repeats. BMC Genomics. 2006;7:258–65. doi:10.1186/1471-2164-7-258.
McConkey DJ, Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat. 2008;11:164–79. doi:10.1016/j.drup.2008.08.002.
Arkin M. Protein-protein interactions and cancer: small molecules going in for the kill. Curr Opin Chem Biol. 2005;9:317–24. doi:10.1016/j.cbpa.2005.03.001.
Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL, Korsmeyer SJ. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science. 2004;305:1466–70.
Ludwig H, Khayat D, Giaccone C, Facon T. Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. Cancer. 2005;104:1794–807. doi:10.1002/cncr.21414.
Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMillin DG, Miller JW, Mitsiades N. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Invest Opthalmol Vis Sci. 2007;48:4706–19. doi:10.1167/iovs.06-1147.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675–87. doi:10.1093/emboj/17.6.1675.
Caron H, van Schaik B, van der Mee A, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, Heisterkamp S, van Kampen A, Versteeg R. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science. 2001;291:1289–92.
NCI60 Cancer Microarray Project [http://genome-www.stanford.edu/nci60/].
Oncogenomics datasets [http://home.ccr.cancer.gov/oncology/oncogenomics/].
Kitano H. Computational systems biology. Nature. 2002;420:206–10. doi:10.1038/nature01254.
Acknowledgments
We thank Ivet Bahar for insightful comments, Nesrin Ozoren for helpful discussions. We also thank Turkan Haliloglu for providing computational facilities for this study. Elife Zerrin Bagci gratefully acknowledges fellowship provided by TÜBİTAK-BİDEB 2218.
Conflict of interest
Authors do not have any conflict of interest or commercial interest in any product mentioned in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bagci, E.Z., Sen, S.M. & Camurdan, M.C. Analysis of a mathematical model of apoptosis: individual differences and malfunction in programmed cell death. J Clin Monit Comput 27, 465–479 (2013). https://doi.org/10.1007/s10877-013-9468-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10877-013-9468-z